Zinger Key Points
- VanEck Head of Digital Assets Research Matthew Sigel has joined the chorus warning of the emerging risk to Bitcoin treasury firms.
- According to Sigel, Bitcoin treasury firms may still have room to act.
- Semler Scientific may be the first domino to fall.
VanEck Head of Digital Assets Research Matthew Sigel has joined the wave of experts warning that the Bitcoin treasury model popularized by MicroStrategy MSTR faces risks. Sigel said Monday on X that Bitcoin treasury firms risked eroding shareholder value if they traded near their net asset value.
Multiples to NAV have allowed Bitcoin treasury firms to raise capital for Bitcoin purchases by issuing more shares. But in recent weeks, experts have warned that these premiums will likely erode over time as the asset becomes more accessible and normalized and more treasury firms appear.
Don't Miss:
- Trade crypto futures on Plus500 with up to $200 in bonuses — no wallets, just price speculation and free paper trading to practice different strategies.
- Grow your IRA or 401(k) with Crypto – unlock the power of alternative investments including a Crypto IRA within your retirement account.
“If the stock trades at or near NAV, continued equity issuance can dilute rather than create value,” Sigel said. “That is not capital formation. It is erosion.”
However, there may still be room for Bitcoin treasury firms to safeguard against this risk, according to Sigel.
Sigel said Bitcoin treasury firms should announce a pause of at-the-market stock offerings if shares trade below 0.95 times NAV for 10 days or more. This could temporarily prevent further shareholder dilution.
Sigel also said that firms could engage in stock buybacks when Bitcoin rises, but share prices fail to reflect the increased value. This strategy is typically employed when a firm believes its stock is undervalued, and it can often be an effective means of returning shareholder value. Still, its effectiveness is often at the mercy of broader market sentiment.
If all fails, Sigel said, firms might have to consider more drastic measures such as mergers, spinoffs, or sunsetting the Bitcoin treasury strategy.
Trending: New to crypto? Get up to $400 in rewards for successfully completing short educational courses and making your first qualifying trade on Coinbase.
Meanwhile, he warned that Bitcoin treasury firms should avoid outsized executive compensation. He said compensation should reflect NAV per share growth, not the total Bitcoin position or share count.
“Boards and shareholders should act with discipline now, while they still have the benefit of optionality,” he surmised.
Sigel’s warning comes as this NAV risk looks set to become a reality for at least one Bitcoin treasury firm. At last look, Semler Scientific SMLR is trading at 1 times NAV, according to Strategy Tracker.
The firm’s stock has fallen over 45% year-to-date despite multiple Bitcoin purchases over the year and the asset trading near all-time highs.
According to Sigel, Semler Scientific’s troubles may be linked to its small market capitalization, low liquidity and long-standing business issues.
The firm has been at the center of a multiyear Department of Justice probe over whether it misled government programs with false claims about its QuantaFlo test to get more money than it should have from the government. The QuantaFlo test uses Semler Scientific’s QuantaFlo device to test for peripheral artery disease. QuantaFlo has been used by large insurance firms like United Healthcare.
Failure of Semler Scientific to rally could offer insight into what other Bitcoin treasury firms could face and how it could impact the market.
Read Next:
- A must-have for all crypto enthusiasts: Sign up for the Gemini Credit Card today and earn rewards on Bitcoin Ether, or 60+ other tokens, with every purchase.
- Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today.
Image: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.